| Document Date: 2010-06-17 14:46:16
Open Document File Size: 311,19 KBShare Result on Facebook
Company U.S. LLC / / IndustryTerm viscous solution / resultant solution / diluted solution / antineoplastic medicinal products / final infusion solution / containment devices / personal protective equipment / infusion solution / / MedicalCondition neutropenia and renal failure / fatal infectious adverse events / Peripheral Neuropathy7 Dysgeusia / Lymphatic System Disorders / Headache / leukopenia / asthenia / abdominal pain / Mucosal Inflammation / cerebral hemorrhage / nausea / thrombocytopenia / alopecia / patient experiences febrile neutropenia / peripheral neuropathy / Severe hypersensitivity / febrile neutropenia / fatigue / generalized rash/erythema / septic shock / Gastrointestinal Symptoms Nausea / hematuria / back pain / Cardiac Disorders / Hypersensitivity / diarrhea / constipation / infections / Connective Tissue Disorders Back Pain / sepsis / hypotension / prolonged neutropenia / hormone-refractory metastatic prostate cancer / General Disorders / bronchospasm / Neutropenia2 Febrile Neutropenia / disease / Nervous System Disorders / arthralgia / dyspnea / dysgeusia / Hematuria / Carcinogenesis / neutropenia / frequent blood cell counts / neutropenia complications / neutropenia / Spasms / severe diarrhea / documented infection / neutropenia and febrile neutropenia / Renal Failure Renal failure / vomiting / Gastrointestinal Disorders Diarrhea / ventricular fibrillation / Dizziness / cough / Renal failure / anemia / dehydration / / MedicalTreatment Premedication / rehydration / intravenous infusion / radiation / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position qualified physician / General / / Product If JEVTANA Injection / dexamethasone / sodium chloride / The JEVTANA Injection / dextrose / JEVTANA Injection / prednisone / mitoxantrone / / Technology radiation / Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
JEVTANA (cabazitaxel) injection Label